PW Medtech Group (HKG:1358) expects an attributable profit of between 83 million yuan and 102 million yuan for the year 2025, down 32% to 45% from 150.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.
The medical device company attributed the forecast to a drop in sales in the infusion set segment.